Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deedra Nicolet

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2013
Reply to K. Orendi et alKrzysztof Mrózek, Deedra Nicolet, Kati S Maharry, et al.
Statistics in Medicine|July 6, 2022
Controlled variable selection in Weibull mixture cure models for high-dimensional dataHan Fu, Deedra Nicolet, Krzysztof Mrózek, et al.
Briefings in Bioinformatics|October 2, 2022
High-dimensional genomic feature selection with the ordered stereotype logit modelAnna Eames Seffernick, Krzysztof Mrózek, Deedra Nicolet, et al.
Haematologica|July 30, 2016
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)Christian Niederwieser, Deedra Nicolet, Andrew J Carroll, et al.
Biomarker Research|May 29, 2026
A gene signature derived from leukemia associated macrophages provides a compelling risk stratification for human AML patientsDeedra Nicolet, Ting Zhang, Christopher J Walker, et al.
Blood|March 6, 2014
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AMLViolaine Havelange, Parvathi Ranganathan, Susan Geyer, et al.
British Journal of Haematology|August 2, 2016
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemiaBhavana Bhatnagar, Ann-Kathrin Eisfeld, Deedra Nicolet, et al.
Journal of Hematology & Oncology|May 3, 2024
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure modelKellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2013
Reply to K. Orendi et alKrzysztof Mrózek, Deedra Nicolet, Kati S Maharry, et al.
Statistics in Medicine|July 6, 2022
Controlled variable selection in Weibull mixture cure models for high-dimensional dataHan Fu, Deedra Nicolet, Krzysztof Mrózek, et al.
Briefings in Bioinformatics|October 2, 2022
High-dimensional genomic feature selection with the ordered stereotype logit modelAnna Eames Seffernick, Krzysztof Mrózek, Deedra Nicolet, et al.
Haematologica|July 30, 2016
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)Christian Niederwieser, Deedra Nicolet, Andrew J Carroll, et al.
Biomarker Research|May 29, 2026
A gene signature derived from leukemia associated macrophages provides a compelling risk stratification for human AML patientsDeedra Nicolet, Ting Zhang, Christopher J Walker, et al.
Blood|March 6, 2014
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AMLViolaine Havelange, Parvathi Ranganathan, Susan Geyer, et al.
British Journal of Haematology|August 2, 2016
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemiaBhavana Bhatnagar, Ann-Kathrin Eisfeld, Deedra Nicolet, et al.
Journal of Hematology & Oncology|May 3, 2024
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure modelKellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
Pageof 8